Literature cited
M. D. Mashkovskii, M. G. Pleshakov, and R. A. Al'tshuler, Khim. Farm. Zh., No. 2, 60 (1975).
C. Giurgea, Actual. Pharmacol., Ser. 25, 115 (1972).
C. Giurgea and F. Moyersoons, Arch. Int. Pharmacodyn.,166, 238 (1967).
C. Giurgea, Rev. Neurol.,122, 484 (1970).
C. Giurgea and D. Lefevre, Psychopharmacologia (Berlin),20, 160 (1971).
F. Moyersoons and C. Giurgea, Arch. Int. Pharmacodyn.,179, 388 (1969).
C. Giurgea and F. Moyersoons, Arch.,199, 67 (1972).
S. Sara and D. Lefevre, Psychopharmocologia (Berlin),25, 35 (1972).
O. L. Wolthuis, Eur. J. Pharmacol.,16, 283 (1971).
C. Giurgea, Cond. Reflex,8, No. 2, 108 (1973).
C. Hörig and H. Koch, Pharmazie,29, 626 (1974).
B. Rubin, M. H. Malone, et al., J. Pharmacol. Exp. Ther.,120, 125 (1957).
S. Corne, R. W. Pickering, and B. T. Warner, Br. J. Pharmacol.,20, 106 (1963).
R. A. Janssen and C. Niemegeers, Arzneimittelforschung,15, 104 (1965).
G. Woolfe and A. McDonald, J. Pharmacol. Exp. Ther.,80, 300 (1944).
M. E. Kaminka, Farmakol. Toksikol., No. 2, 229 (1975).
Author information
Authors and Affiliations
Additional information
N. I. Andreeva, M. E. Kaminka, M. A. Muratov, V. A. Parshin, T. K. Trubitsyna, I. M. Sharapov, and G. Ya. Shvarts took part in carrying out individual investigations of the experimental section of the present work.
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 11, No. 8, pp. 132–138, August, 1977.
Rights and permissions
About this article
Cite this article
Mashkovskii, M.D., Roshchina, L.F., Polezhaeva, A.I. et al. Special pharmacological features of pyracetam. Pharm Chem J 11, 1142–1147 (1977). https://doi.org/10.1007/BF00778200
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00778200